Heart failure, the clinical syndrome that arises from inadequate cardiac pump function, is known to be influenced by genetic factors. However, thus far unbi-ased genetic approaches in humans have met with limited success in identifying heart failure modifier genes [1], likely because of substantial genetic heterogene-ity between patients and difficulty control-ling environmental factors. These limita-tions can be overcome in model systems such as the mouse, where a wealth of inbred lines, polymorphic markers, and well-characterized heart failure models are available. Taking advantage of thes
Congenital heart disease (CHD) is a major cause of childhood morbidity and death in the West; the in...
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of ...
Heart failure is a clinical syndrome characterized by an inability of the heart to meet oxygen deman...
Heart failure (HF) is the leading cause of death worldwide. It is a complex disease involving multip...
The genetics of heart failure is complex. In familial cases of cardiomyopathy, where mutations of la...
Heart failure (HF) accounts for 1 in 9 deaths in the United States and is the leading cause of hospi...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Genetic factors are known to modulate cardiac susceptibility to ventricular hypertrophy and failure....
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of ...
The cardiovascular system is critically important in the transport of oxygen and nutrients in higher...
Congenital heart disease (CHD) is a major cause of childhood morbidity and death in the West; the in...
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of ...
Clinical presentation of congenital heart disease is heterogeneous, making identification of the di...
Congenital heart disease (CHD) is a major cause of childhood morbidity and death in the West; the in...
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of ...
Heart failure is a clinical syndrome characterized by an inability of the heart to meet oxygen deman...
Heart failure (HF) is the leading cause of death worldwide. It is a complex disease involving multip...
The genetics of heart failure is complex. In familial cases of cardiomyopathy, where mutations of la...
Heart failure (HF) accounts for 1 in 9 deaths in the United States and is the leading cause of hospi...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Genetic factors are known to modulate cardiac susceptibility to ventricular hypertrophy and failure....
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of ...
The cardiovascular system is critically important in the transport of oxygen and nutrients in higher...
Congenital heart disease (CHD) is a major cause of childhood morbidity and death in the West; the in...
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of ...
Clinical presentation of congenital heart disease is heterogeneous, making identification of the di...
Congenital heart disease (CHD) is a major cause of childhood morbidity and death in the West; the in...
We describe a simple bioinformatics method for biomarker discovery that is based on the analysis of ...
Heart failure is a clinical syndrome characterized by an inability of the heart to meet oxygen deman...